NFE2L2 and cardiomyopathy: This also aligns with the work conducted by Fang et al., which presented evidence supporting the role of ferroptosis in doxorubicin-induced cardiomyopathy through an NRF2-mediated mechanism, involving its downstream gene HMOX1 [52], which was also upregulated in our model, implying a potential convergence towards comparable pathways.